FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAtriCure, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ATRC
AtriCure, Inc. Stock AnalysisComprehensive stock analysis for AtriCure, Inc. (ATRC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisATRC
ATRC
AtriCure, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ATRC
  1. Home
  2. Stocks
  3. AtriCure, Inc.

AtriCure, Inc.

🇺🇸ATRC•NASDAQ

AtriCure, Inc.

🇺🇸ATRC•NASDAQ
Market cap
$2.82B
Sentiment

Your view on ATRC

Mkt Cap
$2.82B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About AtriCure, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael H. Carrel
Headquarters
7555 Innovation Way, Mason, OH, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael H. Carrel
Headquarters
7555 Innovation Way, Mason, OH, US
Description

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.

The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation.

It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes.

In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves.

It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for AtriCure, Inc. from FRC's valuation model, read against the market price. ATRC last traded at $55.45, 184.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for AtriCure, Inc.. Starting points for AtriCure, Inc.: P/E 184.6, EPS $0.30, beta 1.21 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for AtriCure, Inc.. AtriCure, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for AtriCure, Inc.. Trailing twelve-month EPS for AtriCure, Inc. stands at $0.30. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$59.22

average of 9 firms, last 12 months

 

$59.22

Low $44.00

Median $60.00

High $70.00

 

Analyst Ratings

Buy9 firms, last 12 months
  • Strong Buy0
  • Buy6
  • Hold3
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate-$0.01$0.03$0.23$0.47
Low estimate-$0.02-$0.07$0.15$0.37
High estimate$0.00$0.16$0.27$0.51
No. of analysts5467
Year-ago EPS$0.061$0.001-$0.241—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$159.44M$158.32M$608.45M$682.18M
Low estimate$159.34M$157.75M$608.33M$678.85M
High estimate$159.65M$159.25M$608.73M$684.34M
No. of analysts7588
Year-ago revenue$140.50M$141.25M$534.53M—
Growth+13.5%+12.1%+13.8%—
Recent analyst actions15 rating and price-target changes, latest Nov 12, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for AtriCure, Inc.. AtriCure, Inc. has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ATRC17 companies · 8 funds
Compare ATRC with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ADGMAdagio Medical Holdings, Inc.Medical - Devices$1M
  • BSXBoston Scientific CorporationMedical - Devices$63.3B
  • EWEdwards Lifesciences CorporationMedical - Devices$60.5B
  • LIVNLivaNova PLCMedical - Devices$5.2B
  • MDTMedtronic plcMedical - Devices$128.8B

More Medical - Instruments & Supplies companies

  • VSMDVasamed, Inc.OTC$802
  • WHSIWearable Health Solutions, Inc.OTC$182,671
  • WSTWest Pharmaceutical Services, Inc.NYSE$28.1B
  • XRAYDENTSPLY SIRONA Inc.NASDAQ$1.7B
  • YBGJYubo International Biotech LimitedOTC$1M
  • ZJYLJin Medical International Ltd.NASDAQ$26M
  • SHWGYShandong Weigao Group Medical Polymer Company LimitedOTC$3.0B
  • SMTISanara MedTech Inc.NASDAQ$301M
  • SOAGYSartorius AGOTC$82.3B
  • SOLVSolventum CorporationNYSE$14.7B
  • SRTOYSartorius Stedim Biotech S.A.OTC$209.8B
  • SSSGYSartorius AGOTC$15.8B

ETFs holding AtriCure, Inc.

% of the fund

  • IJRiShares Core SP Small-Cap ETF$103.8B in assets0.16%
  • IWMiShares Russell 2000 ETF$76.6B in assets0.10%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
  • VBVanguard Small-Cap ETF$76.9B in assets0.04%
  • XHEState Street SPDR S&P Health Care Equipment ETF$163M in assets1.62%
  • PSCHInvesco S&P SmallCap Health Care ETF$188M in assets1.54%
  • HAPSHarbor Human Capital Factor US Small Cap ETF (HAPS)$190M in assets1.51%
  • PTHInvesco Dorsey Wright Healthcare Momentum ETF$293M in assets1.33%

Largest holders first, then the funds most concentrated in ATRC.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold AtriCure, Inc., and how their positions are changing. At a $2.82B market value, institutional positions materially move AtriCure, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by AtriCure, Inc. executives and directors. Shares of AtriCure, Inc. have traded between $28.29 and $43.11 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming AtriCure, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for AtriCure, Inc.. Coverage tracks AtriCure, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of AtriCure, Inc.

ATRC Analysis
Fair
Past2
Growth5
Health4
Profit1
Value1

News

Latest Market News